Degenerative Lesion of Articular Cartilage of Knee Clinical Trial
— LOGICOfficial title:
Observational Studies, Prospective, Multicenter, to Evaluate the Effect of Treatment of Knee Osteochondral Lesions of Outerbridge Grade III-IV
Verified date | May 2014 |
Source | Ettore Sansavini Health Science Foundation |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ministry of Health |
Study type | Observational |
The purpose of the study is to evaluate prospectively the outcome of treatment interventions of knee osteochondral lesions Outerbridge grade III and IV.
Status | Completed |
Enrollment | 20 |
Est. completion date | November 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 30 Years to 60 Years |
Eligibility |
Inclusion criteria: patients referred to the participating centers for symptomatic treatment of degenerative lesions of the knee, which meet the following inclusion criteria: - symptomatic osteochondral lesions of grade III or IV (according to classification of Outerbridge; - Axial deviation with chondral damage, correct or not; - Consent to the processing of personal data, signed and dated by patient; - Patients of both sexes and aged between 30 and 60 years; - Patients willing to participate actively in the rehabilitation program and to attend post-operative follow-up visits. Exclusion criteria: - Patients with synovitis; - BMI> 30; - Allergy to collagen or calcium phosphate; - Patients with neoplastic disease; - Patients with metabolic disorders, thyroid diseases, immune system disorders. |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Italy | Andrea Mocci | Bari | |
Italy | Raul Zini | Cotignola | Ravenna |
Italy | Maurizio Bellettato | Faenza | Ravenna |
Italy | Luisangelo Sordo | Torino |
Lead Sponsor | Collaborator |
---|---|
Ettore Sansavini Health Science Foundation |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Score | Primary outcome measure will be the outcome of innovative treatments with repairing, regenerative and replacement techniques, with or without associated osteotomy, of knee osteochondral severe lesions(Outerbridge grade III and IV) in terms of symptoms improvement as assessed by means of the International Knee Documentation Committee (IKDC) subjective Knee Evaluation Score at 12 months postoperatively. | 12 months post procedure | No |
Secondary | functional recovery at International Knee Documentation Committee(IKDC) knee Examination | 12 months | No | |
Secondary | Physical performance at Tegner activity score | 12 months post surgery | No | |
Secondary | functional activity on the Lysholm Knee Scale | 12 months post surgery | No | |
Secondary | Tissue regeneration at magnetic resonance (MRI) | 12 months post surgery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02090140 -
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
|
N/A | |
Active, not recruiting |
NCT02345564 -
Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery
|
N/A | |
Completed |
NCT02285725 -
Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid
|
N/A | |
Recruiting |
NCT04000659 -
Episealer® Knee System IDE Clinical Study
|
N/A | |
Terminated |
NCT02981355 -
Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions
|
Phase 4 | |
Completed |
NCT01576159 -
Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises
|
Phase 0 | |
Active, not recruiting |
NCT01329445 -
DeNovo NT Longitudinal Data Collection (LDC) Knee Study
|
N/A | |
Completed |
NCT01605201 -
Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage
|
Phase 1 |